(Q44493051)

3 December 2017

title

Postoperative adjuvant gemcitabine and concurrent radiation after curative resection of pancreatic head carcinoma: a phase II study (English)

1 reference

3 December 2017

Jean-Luc Van Laethem

1

1 reference

3 December 2017

Anne Demols

2

1 reference

3 December 2017

France Gay

3

1 reference

3 December 2017

Marie-Thérèse Closon

4

1 reference

3 December 2017

Maryvone Collette

5

1 reference

3 December 2017

Marc Polus

6

1 reference

3 December 2017

Ghislain Houbiers

7

1 reference

3 December 2017

Pauline Gastelblum

8

1 reference

3 December 2017

Michel Gelin

9

1 reference

3 December 2017

Paul Van Houtte

10

1 reference

3 December 2017

Jean Closset

11

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

International Journal of Radiation Oncology Biology Physics

3 December 2017

published in

1 reference

3 December 2017

volume

56

1 reference

3 December 2017

issue

4

1 reference

3 December 2017

page(s)

974-980

1 reference

AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900164-0

7 January 2021

Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900164-0

7 January 2021

Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900164-0

7 January 2021

Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900164-0

7 January 2021

Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900164-0

7 January 2021

Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900164-0

7 January 2021

Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900164-0

7 January 2021

Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900164-0

7 January 2021

Continuing controversy over adjuvant therapy of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900164-0

7 January 2021

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900164-0

7 January 2021

Radiosensitization of pancreatic cancer cells by 2',2'-difluoro-2'-deoxycytidine

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900164-0

7 January 2021

Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900164-0

7 January 2021

Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900164-0

7 January 2021

Adjuvant radiotherapy and concomitant 5-fluorouracil by protracted venous infusion for resected pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900164-0

7 January 2021

Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900164-0

7 January 2021

Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900164-0

7 January 2021

The influence of the schedule and the dose of gemcitabine on the anti-tumour efficacy in experimental human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900164-0

7 January 2021

10.1016/S0360-3016(03)00164-0

Identifiers

DOI

1 reference

3 December 2017

1 reference